
  
    
      
        Background_NNP
        DNA_NN topoisomerase_NN I_PRP (_( TOP_NNP 1_LS )_) is_VBZ a_DT ubiquitously_RB expressed_VBN
        protein_NN that_IN relaxes_NNS DNA_NNP supercoils_NNS generated_VBN during_IN many_JJ
        transactions_NNS of_IN DNA_NNP including_VBG replication_NN ,_, transcription_NN ,_,
        repair_NN ,_, and_CC chromatin_NN condensation_NN and_CC remodeling_VBG ._. TOP_NNP 1_CD has_VBZ
        been_VBN shown_VBN to_TO interact_NN with_IN many_JJ proteins_NNS including_VBG
        components_NNS of_IN the_DT holo_NN TFIIIC_NNP complex_JJ [_NN 1_CD ]_NN ,_, TFIID_NNP [_NN 2_CD ]_NN ,_,
        p_NN 53_CD [_NN 3_CD ]_NN ,_, SV-_NNP 40_CD large_JJ T_NN antigen_NN [_NN 4_CD ]_NN ,_, nucleolin_NN [_NN 5_CD ]_NN ,_,
        the_DT RING_NNP finger_NN protein_NN topors_NNS [_NN 6_CD ]_NN ,_, the_DT RNA_NNP splicing_VBG
        factors_NNS PSF_NNP /_NN p_NN 54_CD nrb_NN [_NN 7_CD ]_NN and_CC SF_NNP 2_CD /_NN ASF_NNP [_NN 8_CD ]_NN ,_, the_DT cell_NN
        cycle_NN regulatory_JJ protein_NN ARF_NNP [_NN 9_CD ]_NN ,_, RNA_NNP pol_NN II_NNP complex_JJ [_NN
        10_CD 11_CD ]_NN ,_, and_CC HTLV_NNP type_NN 1_CD tax_NN oncoprotein_NN [_NN 12_CD ]_NN ._. TOP_NNP 1_CD
        also_RB interacts_NNS with_IN a_DT variety_NN of_IN unidentified_JJ proteins_NNS
        involved_VBN in_IN its_PRP$ phosphorylation_NN ,_, ubiquitination_NN and_CC
        sumoylation_NN [_NN 13_CD 14_CD 15_CD 16_CD 17_CD ]_NN ._.
        We_PRP used_VBD the_DT core_NN domain_NN of_IN TOP_NNP 1_CD lacking_VBG the_DT N-_NNP terminal_NN
        highly_RB charged_VBD region_NN ,_, the_DT coiled-coil_JJ linker_NN domain_NN and_CC
        the_DT C-_NNP terminal_NN active_JJ site_NN domain_NN as_IN bait_NN in_IN two_CD hybrid_JJ
        screens_NNS for_IN TOP_NNP 1_CD interacting_VBG proteins_NNS ._. We_PRP obtained_VBD multiple_JJ
        independent_JJ cDNA_NN clones_NNS coding_VBG for_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD ,_, two_CD
        uncharacterized_JJ ,_, BTB_NNP domain-containing_JJ ,_, kelch-like_JJ
        proteins_NNS ._. The_DT interactions_NNS of_IN HeLa_NNP cell_NN TOP_NNP 1_CD with_IN the_DT BTBD_NNP
        proteins_NNS was_VBD confirmed_VBN using_VBG GST-pulldown_NNP and_CC was_VBD further_RBR
        suggested_VBN by_IN their_PRP$ intracellular_NN co-localization_JJ ._.
      
      
        Results_NNS
        
          Identification_NNP of_IN TOP_NNP 1_CD -_: interacting_VBG proteins_NNS using_VBG
          two-hybrid_JJ assays_NNS
          The_DT core_NN domain_NN of_IN human_JJ TOP_NNP 1_CD from_IN residue_NN 198_CD to_TO 651_CD
          was_VBD used_VBN as_IN the_DT bait_NN in_IN two-hybrid_JJ screens_NNS [_NN 18_CD 19_CD 20_CD ]_NN ._.
          This_DT region_NN of_IN TOP_NNP 1_CD lacks_VBZ the_DT N-_NNP terminal_NN ~_NN 25_CD %_NN of_IN the_DT
          protein_NN that_WDT is_VBZ highly_RB charged_VBN and_CC the_DT C-_NNP terminal_NN domain_NN
          containing_VBG the_DT active_JJ site_NN and_CC the_DT coiled-coil_JJ linker_NN ._.
          The_DT resulting_VBG polypeptide_NN comprises_VBZ 60_CD %_NN of_IN the_DT TOP_NNP 1_CD
          sequence_NN ._. A_DT screen_NN of_IN a_DT HeLa_NNP cell_NN library_NN yielded_VBD 56_CD
          colonies_NNS that_WDT tested_VBD positive_JJ in_IN the_DT two_CD hybrid_JJ assays_NNS
          (_( growth_NN on_IN plates_NNS lacking_VBG histidine_NN or_CC uracil_NN ,_, lack_NN of_IN
          growth_NN on_IN plates_NNS containing_VBG 5_CD -_: fluoroorotic_JJ acid_NN ;_: and_CC
          induction_NN of_IN 
          lacZ_NN resulting_VBG in_IN blue_JJ color_NN when_WRB
          assayed_JJ with_IN X-_NNP gal_NN )_) ._. Nucleotide_NNP sequence_NN analysis_NN of_IN 34_CD
          of_IN these_DT clones_NNS revealed_VBD two_CD cDNA_NN contigs_NNS of_IN 15_CD and_CC 19_CD
          that_WDT predict_VBP proteins_NNS whose_WP$ sequences_NNS are_VBP 80_CD %_NN identical_JJ ._.
          The_DT proteins_NNS were_VBD named_VBN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD according_VBG to_TO a_DT
          recent_JJ analysis_NN of_IN their_PRP$ genomic_JJ sequences_NNS [_NN 21_CD ]_NN ._. The_DT
          clones_NNS of_IN each_DT contig_NN differed_VBD in_IN the_DT amount_NN of_IN 5_CD '_POS
          sequence_NN present_JJ :_: 11_CD /_NN 15_CD and_CC 15_CD /_NN 19_CD of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD ,_,
          respectively_RB ,_, had_VBD different_JJ 5_CD '_POS ends_NNS ._. In_IN the_DT two-hybrid_JJ
          growth_NN assays_NNS and_CC β-galactosidase_JJ assays_NNS ,_, each_DT of_IN the_DT
          clones_NNS tested_VBN as_RB positive_JJ as_IN the_DT control_NN for_IN strongly_RB
          interacting_VBG proteins_NNS (_( the_DT interaction_NN of_IN c-_NN Fos_NNP with_IN
          c-_NN Jun_NNP ,_, ProQuest_NNP ,_, Life_NNP Technologies_NNPS )_) ._. Another_DT two-hybrid_JJ
          screen_NN using_VBG a_DT different_JJ two-hybrid_JJ system_NN (_( Matchmaker_NNP ,_,
          Clontech_NNP )_) also_RB yielded_VBD 2_CD clones_NNS identical_JJ to_TO the_DT contig_NN
          of_IN 15_CD clones_NNS (_( BTBD_NNP 1_LS )_) ._.
        
        
          Characterization_NNP of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD mRNA_NN
          The_DT longest_JJS BTBD_NNP 1_CD cDNA_NN clone_NN obtained_VBN from_IN two-hybrid_JJ
          screening_NN (_( 3196_CD bp_NN )_) contains_VBZ an_DT ORF_NNP that_IN encodes_NNS a_DT 482_CD aa_NN
          protein_NN starting_VBG with_IN an_DT ATG_NNP that_WDT is_VBZ preceded_VBN by_IN an_DT
          in-frame_JJ stop_NN codon_NN ._. Sequences_NNP in_IN GenBank_NNP confirmed_VBD our_PRP$
          sequence_NN ._. One_CD was_VBD obtained_VBN by_IN the_DT oligo-capping_JJ method_NN
          (_( FLJ_NNP 20724_CD )_) ,_, and_CC another_DT assembled_VBN from_IN partial_JJ cDNA_NN and_CC
          RACE_NNP fragments_NNS [_NN 21_CD ]_NN ._.
          The_DT longest_JJS BTBD_NNP 2_CD cDNA_NN obtained_VBN from_IN two-hybrid_JJ
          screening_NN (_( 2413_CD bp_NN )_) contained_VBD an_DT ORF_NNP starting_VBG at_IN the_DT 5_CD '_POS
          end_NN ._. To_TO obtain_VB the_DT missing_VBG 5_CD '_POS cDNA_NN ,_, a_DT nested_JJ PCR_NNP strategy_NN
          was_VBD used_VBN to_TO amplify_VB the_DT sequence_NN from_IN four_CD independent_JJ
          cDNA_NN libraries_NNS ,_, but_CC no_DT extended_VBN sequences_NNS were_VBD obtained_VBN ._.
          5_LS '_POS -_: RACE_NNP (_( Life_NNP Technologies_NNPS )_) also_RB failed_VBD to_TO produce_VB longer_JJR
          clones_NNS ._. This_DT difficulty_NN to_TO obtain_VB longer_JJR cDNA_NN clones_NNS was_VBD
          seen_VBN by_IN others_NNS [_NN 21_CD ]_NN ._. The_DT GC_NNP richness_NN at_IN the_DT 5_CD '_POS end_NN (_( 85_CD
          nucleotides_NNS are_VBP 79_CD %_NN GC_NNP )_) may_MD form_VB secondary_JJ structures_NNS
          that_WDT block_VBP reverse_VB transcriptase_NN ._. Analysis_NNP of_IN the_DT BTBD_NNP 2_CD
          gene_NN immediately_RB upstream_RB of_IN the_DT 5_CD '_POS end_NN of_IN our_PRP$ cDNA_NN
          predicts_VBZ an_DT ORF_NNP that_WDT begins_VBZ with_IN an_DT ATG_NNP and_CC encodes_NNS 85_CD
          amino_JJ acids_NNS in-frame_JJ with_IN the_DT ORF_NNP of_IN our_PRP$ longest_JJS BTBD_NNP 2_CD
          clone_NN ;_: however_RB ,_, the_DT 255_CD nucleotides_NNS encoding_VBG these_DT
          in-frame_JJ amino_JJ acids_NNS sequence_NN are_VBP 89_CD %_NN GC_NNP rich_JJ ._. To_TO
          determine_VB if_IN this_DT sequence_NN might_MD be_VB part_NN of_IN the_DT BTBD_NNP 2_CD
          mRNA_NN ,_, RT-PCR_NNP followed_VBN by_IN nested_JJ PCR_NNP was_VBD used_VBN ._. Two_CD
          antisense_NN primers_NNS complementary_JJ to_TO exon_NN 2_CD were_VBD used_VBN to_TO
          prime_JJ reverse_NN transcription_NN ._. Sense_NN primers_NNS for_IN PCR_NNP
          amplification_NN were_VBD located_VBN within_IN predicted_VBD exon_NN 1_CD (_( Fig_NNP ._.
          1_LS A_DT )_) ._. Amplified_NNP products_NNS of_IN 460_CD and_CC 306_CD bp_NN that_WDT are_VBP
          predicted_VBN from_IN the_DT mRNA_NN template_NN resulted_VBD (_( Fig_NNP ._. 1_LS B_NNP )_) ._. If_IN
          genomic_JJ DNA_NNP had_VBD been_VBN the_DT template_NN ,_, products_NNS greater_JJR than_IN
          18_CD kb_NN would_MD have_VB been_VBN obtained_VBN ._. Furthermore_RB ,_, sequencing_VBG
          of_IN the_DT 460_CD bp-amplification_JJ product_NN confirmed_VBD it_PRP to_TO be_VB
          the_DT predicted_VBN mRNA_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. The_DT cDNA_NN starting_VBG at_IN the_DT
          predicted_VBN start_NN codon_NN was_VBD deposited_VBN in_IN GenBank_NNP
          (_( AF_NNP 355797_CD )_) ._.
        
        
          Northern_NNP blotting_VBG and_CC in_IN silico_NN expression_NN
          analysis_NN
          Northern_NNP blotting_VBG was_VBD used_VBN to_TO determine_VB the_DT tissue_NN
          distribution_NN and_CC sizes_NNS of_IN the_DT mRNA_NN encoding_VBG BTBD_NNP 1_CD and_CC
          BTBD_NNP 2_CD (_( Fig_NNP ._. 2_LS )_) ._. Poly_NNP (_( A_DT )_) +_NN RNA_NNP from_IN human_JJ tissues_NNS (_( 2_CD
          μg_NN /_NN lane_NN )_) was_VBD probed_JJ with_IN BTBD_NNP 1_CD ,_, BTBD_NNP 2_CD or_CC TOP_NNP 1_CD cDNA_NN ._. Each_DT
          mRNA_NN was_VBD detected_VBN in_IN all_PDT the_DT tissues_NNS tested_VBN ._. BTBD_NNP 1_CD mRNA_NN
          was_VBD highly_RB expressed_VBN in_IN testes_NNS ,_, heart_NN and_CC skeletal_NN
          muscle_NN ._. BTBD_NNP 2_CD was_VBD more_RBR highly_RB expressed_VBD in_IN skeletal_NN
          muscle_NN ._. Only_RB a_DT single_JJ message_NN size_NN was_VBD detected_VBN for_IN each_DT
          BTBD_NNP 1_CD (_( 3_CD ._. 2_LS kb_NN )_) and_CC BTBD_NNP 2_CD (_( 2_CD ._. 8_CD kb_NN )_) ._.
          BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD cDNA_NN were_VBD found_VBN in_IN libraries_NNS from_IN the_DT
          following_JJ tissues_NNS :_: amniotic_JJ ,_, aorta_NN ,_, bone_NN ,_, brain_NN ,_, bone_NN
          marrow_NN ,_, colon_NN ,_, ear_NN ,_, embryo_NN ,_, foreskin_NN ,_, gall_NN bladder_NN ,_, germ_NN ,_,
          heart_NN ,_, kidney_NN ,_, lung_NN ,_, muscle_NN ,_, ovary_JJ ,_, pancreas_NN ,_,
          parathyroid_NN ,_, placenta_NN ,_, skin_NN ,_, spleen_NN ,_, stomach_NN ,_, testis_NNS ,_,
          thymus_JJ ,_, tonsil_NN and_CC uterus_NN (_( LocusID_NNP 53339_CD and_CC 55643_CD ,_,
          respectively_RB [_NN 22_CD ]_NN )_) ._. BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD was_VBD also_RB expressed_VBN
          in_IN a_DT large_JJ number_NN of_IN tumor_NN types_NNS and_CC normal_JJ tissues_NNS
          present_JJ in_IN SAGE_NNP (_( serial_NN analysis_NN of_IN gene_NN expression_NN )_)
          libraries_NNS (_( SAGEmap_NNP ,_, [_NN 23_CD ]_NN )_) ._.
        
        
          Mapping_NNP of_IN the_DT regions_NNS of_IN TOP_NNP 1_CD and_CC the_DT BTBDs_NNP that_DT
          interact_NN
          BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD were_VBD mapped_VBN by_IN deletion_NN analysis_NN to_TO
          identify_VB amino_JJ acid_NN sequences_NNS required_VBN for_IN interaction_NN
          with_IN TOP_NNP 1_CD ._. In_IN two-hybrid_JJ assays_NNS ,_, N-_NNP terminal_NN deletions_NNS of_IN
          ~_NN 36_CD %_NN of_IN BTBD_NNP 1_CD (_( 177_CD aa_NN )_) or_CC 43_CD %_NN BTBD_NNP 2_CD (_( 228_CD aa_NN )_) did_VBD not_RB
          eliminate_VB binding_JJ to_TO TOP_NNP 1_CD (_( Fig_NNP ._. 3_LS A_DT +_NN B_NNP )_) ._. In_IN contrast_NN ,_,
          C-_NNP terminal_NN deletions_NNS of_IN 112_CD and_CC 33_CD aa_NN of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD ,_,
          respectively_RB ,_, eliminated_VBD binding_JJ to_TO TOP_NNP 1_CD in_IN the_DT
          two-hybrid_JJ assays_NNS ._. Thus_RB sequences_NNS very_RB close_RB to_TO the_DT
          C-_NNP terminus_JJ are_VBP required_VBN for_IN the_DT interaction_NN with_IN TOP_NNP 1_CD by_IN
          this_DT analysis_NN ._.
          Two-hybrid_NNP analysis_NN was_VBD also_RB used_VBN to_TO map_VB regions_NNS of_IN
          the_DT TOP_NNP 1_CD core_NN domain_NN that_DT interact_NN with_IN BTBD_NNP 2_CD ._. The_DT region_NN
          upstream_RB of_IN aa_NN 215_CD and_CC downstream_JJ of_IN aa_NN 329_CD were_VBD not_RB
          required_VBN for_IN binding_JJ BTBD_NNP 2_CD (_( Fig_NNP ._. 3_LS C_NNP )_) ._. The_DT fragment_NN of_IN
          TOP_NNP 1_CD from_IN amino_JJ acid_NN 215_CD to_TO 331_CD was_VBD capable_JJ of_IN binding_JJ to_TO
          BTBD_NNP 2_CD ._. This_DT region_NN includes_VBZ 18_CD aa_NN of_IN core_NN subdomain_NN I_PRP ,_,
          all_DT of_IN core_NN subdomain_NN II_NNP and_CC 10_CD amino_JJ acids_NNS of_IN the_DT second_JJ
          section_NN of_IN core_NN subdomain_NN I_PRP ._.
        
        
          GST-pulldown_NNP assays_NNS confirm_VBP two-hybrid_JJ deletion_NN
          mapping_NN
          Truncated_NNP fragments_NNS of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD were_VBD tested_VBN in_IN
          GST-pull_NNP down_RB assays_NNS for_IN their_PRP$ ability_NN to_TO bind_NN TOP_NNP 1_CD in_IN
          nuclear_JJ extracts_NNS of_IN HeLa_NNP cells_NNS ._. The_DT GST-pulldown_NNP assay_NN
          confirmed_VBD the_DT positive_JJ interactions_NNS seen_VBN in_IN the_DT
          two-hybrid_JJ deletion_NN mapping_NN (_( Fig_NNP ._. 4_LS )_) ._. In_IN addition_NN ,_, we_PRP
          found_VBD that_IN two_CD N-_NNP terminal_NN truncated_JJ BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD were_VBD
          able_JJ to_TO co-precipitate_JJ TOP_NNP 1_CD from_IN nuclear_JJ extracts_NNS (_( BTBD_NNP 1_CD ,_,
          213_CD -_: 482_CD &_CC 303_CD -_: 482_CD ;_: BTBD_NNP 2_CD ,_, 249_CD -_: 525_CD &_CC 289_CD -_: 525_CD )_)
          although_IN they_PRP were_VBD negative_JJ in_IN the_DT two-hybrid_JJ assay_NN ._.
          Since_IN truncated_JJ fragments_NNS may_MD be_VB unstable_JJ in_IN yeast_NN and_CC
          may_MD not_RB accumulate_VBP to_TO levels_NNS sufficient_JJ to_TO produce_VB a_DT
          positive_JJ result_NN ,_, we_PRP used_VBD roughly_RB equal_JJ amounts_NNS of_IN each_DT
          truncated_JJ protein_NN to_TO test_VB for_IN binding_JJ to_TO TOP_NNP 1_CD in_IN nuclear_JJ
          extracts_NNS ._. Taken_VBN together_RB ,_, the_DT results_NNS of_IN the_DT two-hybrid_JJ
          and_CC GST-pulldown_NNP assays_NNS narrow_VB the_DT interacting_VBG region_NN of_IN
          BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD to_TO roughly_RB the_DT C-_NNP terminal_NN half_NN of_IN each_DT
          protein_NN with_IN critical_JJ residues_NNS within_IN the_DT last_JJ 50_CD
          residues_NNS ._.
        
        
          Effect_NN of_IN GST-BTBD_NNP 2_CD on_IN TOP_NNP 1_CD activity_NN
          To_TO test_VB the_DT effect_NN of_IN BTBD_NNP 2_CD on_IN the_DT supercoil_NN
          relaxation_NN activity_NN of_IN TOP_NNP 1_CD ,_, HeLa_NNP cell_NN nuclear_JJ extracts_NNS
          containing_VBG TOP_NNP 1_CD were_VBD incubated_JJ with_IN GST_NNP or_CC GST-BTBD_NNP 2_CD (_( aa_NN
          86_CD -_: 525_CD )_) ._. GST-BTBD_NNP 2_CD slightly_RB inhibited_VBD the_DT supercoil_NN
          relaxation_NN activity_NN of_IN TOP_NNP 1_CD ,_, increasing_VBG the_DT time_NN required_VBN
          to_TO completely_RB relax_VB the_DT supercoiled_JJ DNA_NNP by_IN about_IN two-fold_JJ
          as_IN compared_VBN with_IN GST_NNP alone_RB (_( Fig_NNP ._. 5_LS A_DT )_) ._. The_DT DNA_NNP cleavage_NN
          assay_NN was_VBD also_RB used_VBN to_TO determine_VB if_IN BTBD_NNP 2_CD affected_VBN TOP_NNP 1_CD
          activity_NN ._. This_DT assay_NN measures_VBZ the_DT ability_NN of_IN TOP_NNP 1_CD to_TO
          cleave_NN end-labeled_JJ DNA_NNP substrates_NNS in_IN the_DT presence_NN of_IN the_DT
          anticancer_NN drug_NN camptothecin_NN ,_, which_WDT blocks_VBZ the_DT ligation_NN
          step_NN of_IN the_DT cleavage_NN /_NN religation_NN reaction_NN of_IN TOP_NNP 1_CD ._. A_DT 36_CD
          bp_NN DNA_NNP containing_VBG a_DT single_JJ strong_JJ TOP_NNP 1_CD cleavage_NN site_NN [_NN 24_CD
          ]_NN or_CC a_DT 161_CD bp_NN restriction_NN fragment_NN [_NN 25_CD ]_NN was_VBD used_VBN as_IN the_DT
          substrate_NN ._. GST-BTBD_NNP 2_CD addition_NN produced_VBD a_DT slight_JJ
          inhibition_NN of_IN TOP_NNP 1_CD cleavage_NN activity_NN relative_JJ to_TO GST_NNP
          alone_RB (_( Fig_NNP ._. 5_LS B_NNP )_) on_IN the_DT smaller_JJR substrate_NN and_CC had_VBD no_DT
          detectable_JJ effect_NN on_IN cleavage_NN activity_NN or_CC cleavage_NN site_NN
          selection_NN by_IN TOP_NNP 1_CD on_IN the_DT larger_JJR substrate_NN (_( 5_CD C_NNP )_) ._.
        
        
          Cellular_NNP localization_NN of_IN BTBD_NNP 2_CD and_CC co-localization_JJ
          with_IN TOP_NNP 1_CD
          To_TO determine_VB the_DT localization_NN of_IN BTBD_NNP 2_CD in_IN cells_NNS ,_, we_PRP
          transiently_RB transfected_JJ HeLa_NNP cells_NNS with_IN expression_NN
          plasmids_NNS encoding_VBG either_CC myc-tagged_JJ full_JJ length_NN BTBD_NNP 2_CD
          (_( m-_NN BTBD_NNP 2_CD F_NN )_) or_CC a_DT truncated_JJ BTBD_NNP 2_CD having_VBG the_DT N-_NNP terminal_NN
          half_NN of_IN the_DT BTB_NNP domain_NN removed_VBN (_( m-_NN BTBD_NNP 2_CD T_NN )_) ._. The_DT full_JJ
          length_NN BTBD_NNP 2_CD localized_JJ entirely_RB to_TO cytoplasmic_JJ bodies_NNS
          (_( Fig_NNP ._. 6_CD B_NNP ,_, m-_NN BTBD_NNP 2_CD F_NN )_) ._. The_DT truncated_JJ BTBD_NNP 2_CD localized_JJ
          predominantly_RB to_TO nuclear_JJ bodies_NNS with_IN a_DT minor_JJ fraction_NN
          localizing_VBG to_TO cytoplasmic_JJ bodies_NNS (_( Fig_NNP ._. 6_CD C_NNP ,_, m-_NN BTBD_NNP 2_CD T_NN )_) ._.
          The_DT localization_NN of_IN full_JJ length_NN BTBD_NNP 2_CD to_TO cytoplasmic_JJ
          bodies_NNS was_VBD surprising_VBG because_IN the_DT cytoplasm_NN is_VBZ separated_VBN
          from_IN the_DT nucleus_NN where_WRB endogenous_JJ TOP_NNP 1_CD resides_VBZ and_CC
          transfected_JJ GFP-TOP_NNP 1_CD localizes_NNS [_NN 26_CD 27_CD 28_CD 29_CD 30_CD ]_NN ._.
          Because_IN TOP_NNP 1_CD and_CC BTBD_NNP 2_CD are_VBP not_RB predominantly_RB found_VBD in_IN the_DT
          same_JJ compartments_NNS ,_, they_PRP may_MD interact_NN transiently_RB ,_, or_CC they_PRP
          may_MD interact_NN only_RB under_IN specific_JJ conditions_NNS when_WRB they_PRP may_MD
          be_VB in_IN the_DT same_JJ compartment_NN ._. We_PRP therefore_RB analyzed_VBD mitotic_JJ
          cells_NNS ,_, but_CC did_VBD not_RB observe_VB co-localization_JJ of_IN TOP_NNP 1_CD and_CC
          the_DT BTBDs_NNP (_( not_RB shown_VBN )_) ._. We_PRP then_RB tested_VBD for_IN co-localization_JJ
          in_IN transfected_JJ cells_NNS ._. Though_IN the_DT truncated_JJ m-_NN BTBD_NNP 2_CD T_NN
          localized_VBN to_TO distinct_JJ nuclear_JJ bodies_NNS ,_, its_PRP$ co-localization_JJ
          with_IN endogenous_JJ TOP_NNP 1_CD could_MD not_RB be_VB determined_VBN against_IN the_DT
          background_NN of_IN endogenous_JJ TOP_NNP 1_CD diffuse_NN nuclear_JJ staining_VBG ._.
          However_RB ,_, in_IN cells_NNS co-transfected_JJ with_IN GFP-TOP_NNP 1_CD and_CC
          m-_NN BTBD_NNP 2_CD T_NN ,_, the_DT m-_NN BTBD_NNP 2_CD T_NN staining_VBG was_VBD nuclear_JJ diffuse_NN as_RB
          well_RB as_IN in_IN nuclear_JJ bodies_NNS ,_, indicating_VBG that_DT m-_NN BTBD_NNP 2_CD T_NN
          interacts_NNS with_IN GFP-TOP_NNP 1_CD ,_, which_WDT localizes_NNS throughout_IN the_DT
          nucleus_NN (_( not_RB shown_VBN )_) ._.
          To_TO determine_VB if_IN TOP_NNP 1_CD co-localizes_JJ with_IN BTBD_NNP 2_CD in_IN the_DT
          cytoplasm_NN ,_, GFP-TOP_NNP 1_CD lacking_VBG an_DT NLS_NNP [_NN 30_CD ]_NN was_VBD
          co-transfected_JJ with_IN full_JJ length_NN BTBD_NNP 2_CD (_( m-_NN BTBD_NNP 2_CD F_NN )_) or_CC
          truncated_JJ BTBD_NNP 2_CD (_( m-_NN BTBD_NNP 2_CD T_NN )_) ._. GFP-TOP_NNP 1_CD lacking_VBG a_DT NLS_NNP
          (_( GFP-pTI-_NNP 6_CD )_) localizes_NNS diffusely_RB within_IN the_DT cytoplasm_NN
          (_( Fig_NNP ._. 6_CD Aand_NNP [_NN 30_CD ]_NN )_) ._. In_IN cells_NNS transfected_JJ with_IN both_DT
          GFP-pTI-_NNP 6_CD and_CC full_JJ length_NN m-_NN BTBD_NNP 2_CD F_NN ,_, the_DT diffuse_NN
          cytoplasmic_JJ GFP-pTI-_NNP 6_CD significantly_RB decreased_VBD ,_, and_CC
          GFP-pTI-_NNP 6_CD co-localized_JJ with_IN m-_NN BTBD_NNP 2_CD F_NN to_TO cytoplasmic_JJ
          bodies_NNS (_( Fig_NNP ._. 6_CD D_NNP )_) ._. In_IN cells_NNS transfected_JJ with_IN GFP-pTI-_NNP 6_CD and_CC
          truncated_JJ m-_NN BTBD_NNP 2_CD T_NN ,_, truncated_JJ m-_NN BTBD_NNP 2_CD T_NN was_VBD not_RB in_IN nuclear_JJ
          bodies_NNS as_IN when_WRB transfected_JJ alone_RB ,_, rather_RB it_PRP co-localized_JJ
          with_IN GFP-pTI-_NNP 6_CD to_TO cytoplasmic_JJ bodies_NNS (_( Fig_NNP ._. 6_CD E_NNP )_) ._. Thus_RB ,_,
          when_WRB co-transfected_JJ with_IN GFP-TOP_NNP 1_CD lacking_VBG a_DT NLS_NNP ,_, both_DT
          full_JJ length_NN and_CC the_DT N-_NNP terminal_NN deleted_VBN BTBD_NNP 2_CD co-localized_JJ
          with_IN TOP_NNP 1_CD to_TO cytoplasmic_JJ bodies_NNS ._.
        
      
      
        Discussion_NNP
        Two-hybrid_NNP screens_NNS have_VBP identified_VBN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD as_IN
        proteins_NNS that_WDT interact_NN with_IN the_DT core_NN domain_NN of_IN TOP_NNP 1_CD ._. BTBD_NNP 1_CD
        and_CC BTBD_NNP 2_CD were_VBD isolated_VBN as_IN 15_CD and_CC 19_CD independent_JJ clones_NNS ,_,
        respectively_RB ,_, and_CC in_IN two-hybrid_JJ assays_NNS they_PRP interacted_JJ as_IN
        strongly_RB as_IN the_DT control_NN for_IN strongly_RB interacting_VBG proteins_NNS
        (_( c-_NN Fos_NNP with_IN c-_NN Jun_NNP )_) ._. BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD also_RB bound_VBN HeLa_NNP cell_NN
        TOP_NNP 1_CD (_( 100_CD kDa_NN )_) in_IN nuclear_JJ extracts_NNS by_IN GST-pulldown_NNP assays_NNS ._.
        N-_NNP terminal_NN truncation_NN studies_NNS showed_VBD the_DT C-_NNP terminal_NN 37_CD %_NN to_TO
        45_CD %_NN of_IN the_DT BTBD_NNP proteins_NNS are_VBP sufficient_JJ for_IN binding_JJ TOP_NNP 1_CD ._.
        C-_NNP terminal_NN deletions_NNS of_IN either_DT protein_NN eliminated_VBD binding_JJ
        to_TO TOP_NNP 1_CD (_( C-_NNP terminal_NN truncation_NN of_IN 112_CD aa_NN of_IN BTBD_NNP 1_CD or_CC 33_CD aa_NN
        of_IN BTBD_NNP 2_CD in_IN the_DT two-hybrid_JJ assay_NN ;_: or_CC a_DT C-_NNP terminal_NN
        truncation_NN of_IN 40_CD aa_NN of_IN BTBD_NNP 2_CD in_IN GST-pulldown_NNP )_) ._. Truncation_NNP
        of_IN the_DT BTB_NNP domains_NNS demonstrated_VBN that_IN they_PRP were_VBD not_RB required_VBN
        for_IN interaction_NN with_IN TOP_NNP 1_CD ._. The_DT region_NN of_IN TOP_NNP 1_CD sufficient_JJ
        for_IN binding_JJ BTBD_NNP 2_CD was_VBD narrowed_VBN to_TO residues_NNS 215_CD -_: 329_CD in_IN the_DT
        "_'' cap_NN "_'' region_NN (_( core_NN subdomain_NN II_NNP )_) [_NN 31_CD ]_NN ._. Catalytic_NNP
        activities_NNS of_IN TOP_NNP 1_CD were_VBD affected_VBN slightly_RB or_CC not_RB at_IN all_DT by_IN
        co-incubation_JJ with_IN GST-BTBD_NNP 2_CD suggesting_VBG that_IN the_DT
        interaction_NN does_VBZ not_RB regulate_VB enzyme_NN activity_NN directly_RB ._.
        We_PRP cloned_VBN the_DT full_JJ length_NN BTBD_NNP 1_CD cDNA_NN from_IN a_DT HeLa_NNP cell_NN
        library_NN ._. This_DT sequence_NN is_VBZ 3196_CD bp_NN ,_, and_CC the_DT start_NN codon_NN is_VBZ
        preceded_VBN by_IN a_DT stop_NN codon_NN 6_CD nucleotides_NNS upstream_RB (_( GenBank_NNP ,_,
        FLJ_NNP 20724_CD )_) ._. Our_PRP$ sequence_NN is_VBZ comparable_JJ to_TO two_CD others_NNS in_IN
        GenBank_NNP ,_, one_CD of_IN which_WDT was_VBD obtained_VBN by_IN the_DT oligo-capping_JJ
        method_NN suggesting_VBG that_IN it_PRP begins_VBZ at_IN the_DT 5_CD '_POS cap_NN [_NN 21_CD 32_CD ]_NN
        ._.
        Our_PRP$ repeated_VBN attempts_NNS to_TO clone_NN the_DT 5_CD '_POS end_NN of_IN the_DT BTBD_NNP 2_CD
        by_IN library_NN screening_NN and_CC the_DT RACE_NNP method_NN were_VBD unsuccessful_JJ ._.
        We_PRP tested_VBD sequences_NNS directly_RB upstream_RB of_IN the_DT longest_JJS cDNA_NN
        in_IN the_DT BTBD_NNP 2_CD gene_NN for_IN their_PRP$ presence_NN on_IN the_DT mRNA_NN ._. RT-PCR_NNP
        and_CC sequencing_VBG of_IN the_DT RT-PCR_NNP product_NN demonstrated_VBN that_IN this_DT
        255_CD nucleotide_NN ,_, 89_CD %_NN GC-rich_NNP sequence_NN is_VBZ present_JJ on_IN the_DT
        BTBD_NNP 2_CD mRNA_NN and_CC that_IN it_PRP shares_VBZ predicted_VBD polypeptide_NN
        sequence_NN with_IN BTBD_NNP homologues_NNS and_CC orthologs_NNS ._.
        The_DT BTBD_NNP proteins_NNS contain_VBP an_DT amino_JJ terminal_NN BTB_NNP /_NN POZ_NNP
        domain_NN as_RB well_RB as_IN a_DT C-_NNP terminal_NN region_NN that_WDT is_VBZ related_VBN to_TO
        proteins_NNS that_WDT contain_VBP the_DT kelch_NN domain_NN ._. Neither_DT of_IN these_DT
        regions_NNS yields_NNS unequivocal_NN information_NN for_IN functional_JJ
        classification_NN ._. The_DT BTB_NNP domain_NN is_VBZ a_DT highly_RB conserved_JJ 120_CD
        amino_JJ acid_NN ,_, hydrophobic-rich_JJ ,_, protein-protein_JJ interaction_NN
        domain_NN that_IN mediates_NNS homodimerization_NN and_CC
        heterodimerization_NN of_IN a_DT large_JJ number_NN of_IN proteins_NNS with_IN
        diverse_JJ functions_NNS [_NN 9_CD ]_NN ._. The_DT three_CD dimensional_NN structure_NN
        of_IN one_CD BTB_NNP domain_NN [_NN 33_CD ]_NN has_VBZ been_VBN characterized_VBN through_IN
        structure-function_JJ studies_NNS [_NN 34_CD ]_NN ._. Proteins_NNPS containing_VBG BTB_NNP
        domains_NNS are_VBP currently_RB categorized_VBN into_IN three_CD groups_NNS [_NN 35_CD ]_NN
        :_: 1_LS )_) DNA-binding_NNP proteins_NNS often_RB containing_VBG zinc_NN fingers_NNS in_IN
        the_DT C-_NNP terminal_NN region_NN ,_, 2_LS )_) actin_NN binding_JJ proteins_NNS that_WDT
        contain_VBP a_DT kelch_NN repeat_NN of_IN ~_NN 50_CD residues_NNS that_WDT terminate_VB in_IN a_DT
        pair_NN of_IN glycine_NN residues_NNS [_NN 36_CD ]_NN and_CC 3_LS )_) proteins_NNS that_WDT have_VBP
        neither_DT an_DT actin-binding_JJ domain_NN nor_CC a_DT DNA-binding_NNP domain_NN ._.
        The_DT BTBD_NNP proteins_NNS belong_VBP to_TO the_DT last_JJ category_NN ,_, although_IN
        they_PRP are_VBP distantly_RB related_VBN to_TO kelch_NN proteins_NNS (_( ~_NN 25_CD %_NN
        identical_JJ over_IN ~_NN 250_CD aa_NN )_) ,_, they_PRP lack_VBP the_DT residues_NNS that_WDT are_VBP
        characteristic_NN of_IN kelch_NN repeats_VBZ ,_, a_DT double_JJ glycine_NN sequence_NN
        and_CC a_DT tyrosine_NN separated_JJ from_IN a_DT tryptophan_NN by_IN precisely_RB 6_CD
        residues_NNS [_NN 35_CD 37_CD ]_NN ._.
        BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD are_VBP closely_RB related_VBN sharing_VBG 80_CD %_NN
        identical_JJ amino_JJ acid_NN sequence_NN ._. They_PRP are_VBP one_CD of_IN eleven_CD genes_NNS
        in_IN 19_CD p_NN 13_CD ._. 3_LS →_NN p_NN 12_CD with_IN close_JJ homology_NN to_TO genes_NNS in_IN 15_CD q_NN 24_CD →_NN
        q_NN 26_CD that_WDT have_VBP apparently_RB resulted_VBN from_IN duplications_NNS of_IN a_DT
        common_JJ ancestral_JJ gene_NN [_NN 38_CD ]_NN ._. Both_DT BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD are_VBP
        widely_RB if_IN not_RB ubiquitously_RB expressed_VBD in_IN human_JJ tissues_NNS ._. The_DT
        predicted_VBN promoter_NN regions_NNS are_VBP highly_RB GC-rich_NNP and_CC lack_NN
        canonical_JJ TATA_NNP boxes_NNS ,_, suggesting_VBG that_IN they_PRP may_MD be_VB
        housekeeping_NN genes_NNS [_NN 39_CD 40_CD ]_NN ._.
        Close_NNP mammalian_JJ relatives_NNS of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD include_VBP the_DT
        mouse_NN orthologs_NNS that_WDT are_VBP 98_CD %_NN and_CC 95_CD %_NN identical_JJ
        respectively_RB ,_, as_RB well_RB as_RB highly_RB similar_JJ rat_NN and_CC bovine_JJ
        partial_JJ sequences_NNS [_NN 21_CD ]_NN ._. Sequence_NNP relatives_NNS in_IN lower_JJR
        organisms_NNS include_VBP a_DT 
        C_NNP ._. elegans_NNS sequence_NN with_IN 58_CD %_NN
        identities_NNS with_IN BTBD_NNP 2_CD (_( 429_CD residues_NNS ;_: 2_CD %_NN gaps_NNS ,_, F_NN 38_CD H_NNP 4_CD ._. 7_CD )_) ,_, and_CC
        a_DT 
        D_NNP ._. melanogaster_NN sequence_NN with_IN 46_CD %_NN
        identities_NNS (_( 437_CD residues_NNS ,_, 3_CD %_NN gaps_NNS ,_, CG_NNP 5319_CD )_) ._. The_DT human_JJ
        genome_NN encodes_NNS two_CD proteins_NNS with_IN 46_CD %_NN (_( 436_CD residues_NNS ,_, 3_CD %_NN
        gaps_NNS ,_, CAC_NNP 22147_CD )_) and_CC 45_CD %_NN (_( 497_CD residues_NNS ,_, 5_CD %_NN gaps_NNS ,_, AF_NNP 353674_CD )_)
        identities_NNS compared_VBN with_IN BTBD_NNP 2_CD ._. These_DT proteins_NNS comprise_VBP a_DT
        small_JJ family_NN whose_WP$ members_NNS have_VBP not_RB been_VBN functionally_RB
        characterized_VBN and_CC are_VBP evidently_RB specific_JJ to_TO animals_NNS because_IN
        putative_JJ orthologs_NNS are_VBP not_RB present_JJ in_IN available_JJ fungi_NNS and_CC
        plant_NN sequence_NN databases_NNS ._.
        We_PRP have_VBP demonstrated_VBN an_DT interaction_NN between_IN BTBD_NNP 2_CD and_CC
        TOP_NNP 1_CD by_IN two-hybrid_JJ ,_, GST-pull_NNP down_RB and_CC intracellular_NN
        co-localization_JJ analyses_NNS ._. Studies_NNS are_VBP underway_NN to_TO
        functionally_RB characterize_VB BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD and_CC understand_VB
        their_PRP$ interaction_NN with_IN TOP_NNP 1_CD ._.
      
      
        Conclusions_NNP
        •_NN Fifteen_CD and_CC nineteen_NN independent_JJ cDNA_NN clones_NNS of_IN BTBD_NNP 1_CD
        and_CC BTBD_NNP 2_CD ,_, respectively_RB ,_, were_VBD isolated_VBN from_IN two-hybrid_JJ
        screens_NNS and_CC found_VBD to_TO interact_NN as_RB strongly_RB as_IN c-_NN Fos_NNP
        interacted_JJ with_IN c-_NN Jun_NNP in_IN the_DT two-hybrid_JJ assays_NNS ._.
        •_NN The_DT interactions_NNS of_IN TOP_NNP 1_CD with_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD were_VBD
        confirmed_VBN by_IN deletion_NN mapping_NN using_VBG two-hybrid_JJ and_CC
        GST-pulldown_NNP assays_NNS ._.
        •_NN Less_RBR than_IN the_DT C-_NNP terminal_NN half_NN of_IN each_DT BTBD_NNP protein_NN
        lacking_VBG the_DT BTB_NNP domain_NN is_VBZ sufficient_JJ for_IN binding_JJ to_TO TOP_NNP 1_CD ._.
        TOP_NNP 1_CD from_IN aa_NN 215_CD to_TO 329_CD interacted_JJ with_IN BTBD_NNP 2_CD ._.
        •_NN GFP-BTBD_NNP 2_CD localized_VBN to_TO cytoplasmic_JJ bodies_NNS ._.
        •_NN BTBD_NNP 2_CD had_VBD little_JJ effect_NN on_IN the_DT supercoil_NN relaxation_NN or_CC
        DNA_NNP cleavage_NN activity_NN of_IN TOP_NNP 1_CD in_IN vitro_NN ._.
        •_NN Co-transfected_NNP BTBD_NNP 2_CD and_CC TOP_NNP 1_CD co-localized_JJ ._.
        •_NN The_DT BTBD_NNP 2_CD message_NN contains_VBZ 255_CD nucleotides_NNS that_WDT are_VBP
        89_CD %_NN GC-rich_NNP and_CC are_VBP predicted_VBN to_TO encode_NN the_DT N-_NNP terminus_JJ of_IN a_DT
        525_CD amino_JJ acid_NN protein_NN ._.
        •_NN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD mRNA_NN were_VBD detected_VBN in_IN all_DT human_JJ
        tissues_NNS tested_VBN ._. BTBD_NNP 1_CD mRNA_NN was_VBD highly_RB expressed_VBN in_IN testes_NNS ,_,
        heart_NN and_CC skeletal_NN muscle_NN ._. BTBD_NNP 2_CD was_VBD more_RBR highly_RB expressed_VBD
        in_IN skeletal_NN muscle_NN ._. Only_RB a_DT single_JJ mRNA_NN species_NNS was_VBD present_JJ
        for_IN each_DT BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD ._.
        •_NN Putative_NNP orthologs_NNS of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD are_VBP found_VBN in_IN 
        C_NNP ._. elegans_NNS (_( 58_CD %_NN identities_NNS ,_, 429_CD
        residues_NNS ;_: 2_CD %_NN gaps_NNS ,_, F_NN 38_CD H_NNP 4_CD ._. 7_CD )_) and_CC 
        D_NNP ._. melanogaster_NN (_( 46_CD %_NN identities_NNS ,_, 437_CD
        residues_NNS ,_, 3_CD %_NN gaps_NNS ,_, CG_NNP 5319_CD )_) ._.
        •_NN Two_CD paralogs_NNS of_IN BTBD_NNP 1_CD and_CC BTBD_NNP 2_CD are_VBP present_JJ in_IN the_DT
        human_JJ genome_NN (_( CAC_NNP 22147_CD and_CC AF_NNP 353674_CD )_) ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Plasmid_NNP construction_NN
          To_TO construct_VB the_DT bait_NN expression_NN plasmid_NN (_( pGBD-cTOP_JJ 1_LS )_) ,_,
          the_DT core_NN domain_NN of_IN TOP_NNP 1_CD (_( cTOP_NN 1_CD ,_, amino_JJ acids_NNS 198_CD -_: 651_CD )_) was_VBD
          amplified_VBN by_IN PCR_NNP (_( sense_NN primer_NN :_:
          5_CD '_POS -_: CGGAATTCGAAGAGGAACAGAAGTGGAAATGG-_NNP 3_CD '_POS ;_: antisense_NN primer_NN :_:
          5_CD '_POS -_: CGGGATCCTTAAATCTTAGTTTGCAAGTTCATCAT-_NNP 3_CD '_POS )_) and_CC inserted_VBN
          into_IN the_DT vector_NN pGBD_NN (_( Clontech_NNP )_) cut_VB with_IN EcoRI_NNP and_CC BamHI_NNP ._.
          To_TO construct_VB the_DT cTOP_NN 1_CD expression_NN vector_NN (_( pDBleu-TOP_JJ 1_CD c_SYM )_) ,_,
          cTOP_NN 1_CD was_VBD excised_VBN from_IN pGBD-cTOP_JJ 1_CD with_IN EcoRI_NNP and_CC BamHI_NNP
          and_CC inserted_VBN into_IN the_DT same_JJ sites_NNS in_IN pDBleu_NN (_( ProQuest_NNP ,_,
          Life_NNP Technologies_NNPS )_) ._.
          To_TO construct_VB the_DT GST-fusion_NNP protein_NN expression_NN
          vectors_NNS ,_, the_DT BTBD_NNP inserts_NNS from_IN the_DT prey_NN vector_NN pPC_NN 86_CD were_VBD
          amplified_VBN using_VBG primers_NNS complementary_JJ to_TO the_DT BTBD_NNP coding_VBG
          regions_NNS with_IN additional_JJ Sma_NNP I_PRP and_CC EcoR_NNP I_PRP restriction_NN
          sites_NNS for_IN insertion_NN into_IN these_DT sites_NNS in_IN pGEX-_NN 2_CD TK_NNP
          (_( Pharmacia_NNP )_) ._. These_DT primer_NN sequences_NNS can_MD be_VB found_VBN below_IN
          under_IN the_DT 
          Two_CD Hybrid_NNP Screens_NNP section_NN ._. All_DT
          constructs_NNS were_VBD confirmed_VBN by_IN sequencing_VBG using_VBG pGEX_NN
          sequencing_VBG primers_NNS (_( Pharmacia_NNP Cat_NNP #_# 27_CD -_: 1410_CD -_: 01_CD and_CC
          27_CD -_: 1411_CD -_: 01_CD )_) ._.
          To_TO construct_VB the_DT expression_NN plasmid_NN encoding_VBG
          C-_NNP terminal-myc-tagged_JJ ,_, full_JJ length_NN BTBD_NNP 2_CD (_( m-_NN BTBD_NNP 2_CD F_NN )_) ,_, the_DT
          entire_JJ coding_VBG region_NN of_IN BTBD_NNP 2_CD (_( 1_CD -_: 1575_CD bp_NN )_) was_VBD amplified_VBN
          with_IN primers_NNS (_( Upper_NNP primer_NN :_: 5_CD '_POS
          ATGGCGGCGGGTGGGAGCGGCGGGCGTGCGTCGTG-_NNP 3_CD '_POS ,_, Lower_JJR primer_NN :_:
          5_CD '_POS -_: GGTGTAGAAGATGACCTCGGGGATCTGGCCGTCCTCCAC-_NNP 3_CD '_POS )_) containing_VBG
          BamH_NNP I_PRP and_CC Hind_NNP III_NNP cleavage_NN sites_NNS and_CC inserted_VBN into_IN
          pCMV-Tag_JJ 5_CD vector_NN (_( Stratagene_NNP )_) cut_VB with_IN BamH_NNP I_PRP and_CC Hind_NNP
          III_NNP ._. To_TO construct_VB the_DT expression_NN plasmid_NN encoding_VBG
          C-_NNP terminal-myc-tagged_JJ truncated_JJ BTBD_NNP 2_CD having_VBG the_DT
          N-_NNP terminal_NN half_PDT the_DT BTB_NNP domain_NN deleted_VBN (_( m-_NN BTBD_NNP 2_CD T_NN )_) ,_, the_DT
          coding_VBG region_NN of_IN BTBD_NNP 2_CD from_IN the_DT second_JJ ATG_NNP to_TO almost_RB the_DT
          end_NN of_IN the_DT 3_CD '_POS -_: UTR_NNP (_( 445_CD -_: 2542_CD bp_NN )_) was_VBD amplified_VBN with_IN
          primers_NNS (_( Upper_NNP primer_NN :_:
          5_CD '_POS -_: ATGTTCAACGGGGGAATGGCCACAACATC-_NNP 3_CD '_POS ,_, Lower_JJR primer_NN :_:
          5_CD '_POS -_: GGGGAGGACGCAGGTTCCAGGAGT-_NNP 3_CD '_POS )_) containing_VBG BamH_NNP I_PRP and_CC
          Hind_NNP III_NNP cleavage_NN sites_NNS and_CC inserted_VBN into_IN pCMV-Tag_JJ 3_CD
          vector_NN (_( Stratagene_NNP )_) cut_VB with_IN BamH_NNP I_PRP and_CC Hind_NNP III_NNP ._.
        
        
          Two_CD hybrid_JJ screens_NNS
          pGBD-cTOP_JJ 1_CD was_VBD co-transfected_JJ with_IN the_DT HeLa_NNP cell_NN
          library_NN (_( Clontech_NNP ,_, Cat_NNP ._. no_UH ._. HL_NNP 4000_CD AA_NN )_) into_IN strain_NN PJ_NNP 69_CD -_: 4_CD A_DT
          (_( 
          MAT_NNP a_DT ,_, 
          trp_NN 1_CD -_: 190_CD leu_NN 2_CD -_: 3_CD ,_, 112_CD ura_NN 3_CD -_: 52_CD his_PRP$ 3_CD -_: 200_CD
          gal_NN 4_CD gal_NN 80_CD LYS_NNP 2_CD :_: :_: GAL_NNP 1_CD -_: HIS_PRP$ 3_CD GAL_NNP 2_CD -_: ADE_NNP 2_CD
          met_VBD 2_CD :_: :_: GAL_NNP 7_CD -_: lacZ_NN )_) [_NN 41_CD ]_NN ._. Strong_JJ expression_NN of_IN full_JJ
          length_NN GALDB-TOP_NNP 1_CD in_IN PJ_NNP 69_CD -_: 4_CD A_DT was_VBD verified_VBN by_IN Western_NNP
          blotting_VBG with_IN antibodies_NNS to_TO both_DT TOP_NNP 1_CD and_CC GALDB_NNP (_( not_RB
          shown_VBN )_) ._. Additionally_RB ,_, the_DT ProQuest_NNP two-hybrid_JJ system_NN was_VBD
          used_VBN because_IN the_DT low_JJ copy_NN CEN_NNP plasmids_NNS may_MD decrease_VB the_DT
          probability_NN of_IN obtaining_VBG weakly_RB interacting_VBG false_JJ
          positives_NNS that_WDT could_MD result_VB from_IN high_JJ concentrations_NNS of_IN
          the_DT two-hybrid_JJ proteins_NNS ._. In_IN the_DT ProQuest_NNP screens_NNS ,_,
          pDBleu-TOP_JJ 1_CD c_SYM was_VBD co-transfected_JJ with_IN a_DT HeLa_NNP cell_NN cDNA_NN
          library_NN (_( Life_NNP Technologies_NNPS Cat_NNP ._. No_UH ._. 11287_CD -_: 018_CD )_) according_VBG
          the_DT manufacturer_NN protocols_NNS ._. Clones_NNP that_WDT tested_VBD positive_JJ
          in_IN the_DT two-hybrid_JJ assays_NNS were_VBD sequenced_JJ across_IN the_DT
          GAL_NNP 4_CD AD-prey_NNP junction_NN into_IN the_DT coding_VBG regions_NNS of_IN the_DT prey_NN
          inserts_NNS ._. Sequences_NNP were_VBD grouped_VBN into_IN cDNA_NN contigs_NNS using_VBG
          the_DT SeqMan_NNP II_NNP program_NN of_IN DNASTAR_NNP (_( LASERGENE_NNP )_) ._.
          C-_NNP terminal_NN deletions_NNS for_IN mapping_VBG the_DT interactions_NNS
          using_VBG two-hybrid_JJ assays_NNS were_VBD constructed_VBN using_VBG the_DT
          exonuclease_NN III_NNP /_NN mung_NN bean_NN nuclease_NN method_NN (_( C-_NNP terminal_NN
          deletions_NNS ,_, Exonuclease_NNP III_NNP /_NN Mung_NNP Bean_NNP Nuclease_NNP Deletion_NNP
          kit_NN ,_, Cat_NNP #_# 460_CD ,_, NEW_NNP ENGLAND_NNP BioLabs_NNP company_NN )_) ._. N-_NNP terminal_NN
          deletions_NNS ,_, in_IN addition_NN to_TO the_DT series_NN obtained_VBN through_IN
          two-hybrid_JJ screening_NN ,_, were_VBD constructed_VBN by_IN amplifying_VBG the_DT
          two-hybrid_JJ cDNA_NN clones_NNS using_VBG primers_NNS containing_VBG Sma_NNP I_PRP and_CC
          EcoR_NNP I_PRP at_IN the_DT N-_NNP and_CC C-_NNP terminus_JJ ,_, respectively_RB ,_, and_CC
          inserting_VBG them_PRP into_IN both_DT pPC_NN 86_CD and_CC pGEX-_NN 2_CD TK_NNP vectors_NNS ._. The_DT
          sense_NN primer_NN sequences_NNS are_VBP as_IN follows_VBZ :_: BTBD_NNP 1_CD :_: U_NNP 1_CD
          (_( 395_CD -_: 482_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGGAATGATACCGGCTTTAGTTGTGA-_NNP 3_CD '_POS ,_, U_NNP 2_CD
          (_( 342_CD -_: 482_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGCTGGGGTTACAGTGGGACGAGT-_NNP 3_CD '_POS ,_, U_NNP 3_CD
          (_( 213_CD -_: 482_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGAAGTGCAGAAGGGTTTACT-_NNP 3_CD '_POS ,_, U_NNP 4_CD
          (_( 303_CD -_: 482_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGAAACCTCTTTCTTCATTTTACTGT-_NNP 3_CD '_POS ,_, The_DT
          same_JJ antisense_NN primer_NN was_VBD used_VBN for_IN all_DT amplifications_NNS :_:
          5_CD '_POS -_: CGGAATTCTTTGTGGCCATTTATGTTTTTGAC-_NNP 3_CD '_'' ._. The_DT sense_NN primers_NNS
          for_IN amplification_NN of_IN truncated_JJ BTBD_NNP 2_CD fragments_NNS were_VBD :_: U_NNP 1_CD
          (_( 504_CD -_: 525_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGCTACGCGGCCGGGAACAACAATG-_NNP 3_CD '_POS ,_, U_NNP 2_CD
          (_( 460_CD -_: 525_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGGGTGCTGCCCAACGTCAACTACAC-_NNP 3_CD '_POS ,_, U_NNP 3_CD
          (_( 404_CD -_: 525_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGCGTGGTGGGATTTGGGCTGTATGG-_NNP 3_CD '_POS ,_, U_NNP 4_CD
          (_( 289_CD -_: 525_CD aa_NN )_) 5_CD '_POS -_: GACCCCGGGCCGCTGGTCCGAGGCCGAGTGTC-_NNP 3_CD '_'' ._. The_DT
          same_JJ antisense_NN primer_NN was_VBD used_VBN for_IN all_DT amplifications_NNS :_:
          5_CD '_POS -_: CGGAATTCAACCCCGTCCTGATGCTGAGAAAG-_NNP 3_CD '_''
        
        
          Northern_JJ blots_NNS
          Multiple_NNP tissue_NN Northern_NNP blots_NNS containing_VBG 2_CD μg_NN poly_RB
          (_( A_DT )_) +_NN RNA_NNP (_( Human_NNP Multiple_NNP Tissue_NNP Northern_NNP Blot_NNP IV_NNP and_CC
          Human_NNP Multiple_NNP Tissue_NNP Northern_NNP Blot_NNP ;_: Catalog_NN numbers_NNS :_:
          7766_CD -_: 1_CD and_CC 7760_CD -_: 1_CD ;_: CLONTECH_NNP )_) were_VBD hybridized_JJ with_IN
          32_CD P-_NNP labeled_VBD human_JJ cDNA_NN probes_NNS for_IN TOP_NNP 1_CD (_( nucleotides_NNS
          212_CD -_: 1661_CD ,_, GenBank_NNP accession_NN number_NN J_NNP 03250_CD )_) ,_, BTBD_NNP 1_CD
          (_( nucleotides_NNS 84_CD -_: 3196_CD ,_, GenBank_NNP accession_NN number_NN AF_NNP 355402_CD )_)
          or_CC BTBD_NNP 2_CD (_( nucleotides_NNS 1229_CD -_: 2668_CD ,_, GenBank_NNP accession_NN number_NN
          AF_NNP 355797_CD )_) in_IN Rapid-hyb_NNP buffers_NNS (_( Amersham_NNP Life_NNP Science_NNP ,_,
          RPN_NNP 1635_CD )_) ._. Hybridization_NNP and_CC washing_VBG was_VBD carried_VBN out_IN
          according_VBG to_TO the_DT manufacturer_NN instructions_NNS ._.
        
        
          Isolation_NNP of_IN the_DT BTBD_NNP 2_CD coding_VBG region_NN
          The_DT longest_JJS BTBD_NNP 2_CD cDNA_NN obtained_VBN from_IN two-hybrid_JJ
          screening_NN (_( 2413_CD bp_NN )_) contained_VBD an_DT ORF_NNP starting_VBG at_IN the_DT 5_CD '_POS
          end_NN ._. To_TO obtain_VB the_DT full_JJ coding_VBG region_NN ,_, four_CD independent_JJ
          cDNA_NN libraries_NNS were_VBD screened_VBD using_VBG a_DT nested_JJ PCR_NNP strategy_NN
          with_IN upper_JJ primers_NNS complementary_JJ to_TO the_DT vectors_NNS and_CC two_CD
          nested_JJ lower_JJR primers_NNS complementary_JJ to_TO BTBD_NNP 2_CD
          (_( 5_CD '_POS -_: TCGTCCGAGTAGAGAAAC-_NNP 3_CD '_POS and_CC
          5_CD '_POS -_: TCCACGTCGGGCAGCTCAATCTCC-_NNP 3_CD '_POS )_) ._. 5_LS '_POS -_: RACE_NNP (_( Life_NNP
          Technologies_NNPS )_) was_VBD also_RB used_VBN to_TO try_VB to_TO identify_VB longer_JJR
          clones_NNS using_VBG several_JJ different_JJ lower_JJR primers_NNS ._. Reverse_VBP
          transcription_NN was_VBD also_RB performed_VBN at_IN 70_CD °_NN C_NNP using_VBG the_DT
          thermophilic_JJ 
          Tth_NNP polymerase_NN with_IN magnesium_NN as_IN
          the_DT cofactor_NN to_TO enable_VB it_PRP to_TO use_VB mRNA_NN as_IN a_DT template_NN ._. None_NN
          of_IN these_DT strategies_NNS was_VBD successful_JJ ._.
          To_TO determine_VB whether_IN the_DT mRNA_NN contained_VBD the_DT BTBD_NNP 2_CD gene_NN
          sequences_NNS directly_RB upstream_RB of_IN the_DT longest_JJS cDNA_NN clone_NN ,_,
          RT-PCR_NNP was_VBD used_VBN with_IN a_DT sense_NN primer_NN complementary_JJ to_TO the_DT
          predicted_VBD start_NN codon_NN ._. The_DT primers_NNS for_IN reverse_NN
          transcription_NN were_VBD complementary_JJ to_TO exon_NN 2_CD (_( LO_NNP and_CC LI_NNP ,_,
          see_VB below_IN )_) ._. PolyA_NNP +_NN RNA_NNP was_VBD reverse_VB transcribed_JJ using_VBG 
          Tth_NNP polymerase_NN (_( Promega_NNP )_) at_IN 70_CD °_NN C_NNP
          for_IN 20_CD min_NN ._. The_DT resulting_VBG products_NNS were_VBD amplified_VBN using_VBG
          nested_JJ PCR_NNP with_IN the_DT Advantage-_NNP GC_NNP 2_CD PCR_NNP kit_NN (_( CLONTECH_NNP ,_,
          Cat_NNP #_# K-_NNP 1913_CD -_: Y_NNP )_) and_CC two_CD 30_CD cycle_NN rounds_NNS with_IN each_DT cycle_NN
          having_VBG two_CD steps_NNS (_( denaturation_NN 94_CD °_NN C_NNP ,_, 30_CD sec_NN ._. ;_: annealing_VBG
          and_CC extension_NN 68_CD °_NN C_NNP ,_, 3_CD min_NN ;_: UO_NNP :_:
          5_CD '_POS -_: ATGGCGGCGGGTGGGAGCGGCGGGCGTGCGTCGTG-_NNP 3_CD '_POS ;_: UI_NNP :_:
          5_CD '_POS -_: CGGGCCCCGGGACAGACG-_NNP 3_CD '_POS ;_: LO_NNP :_:
          5_CD '_POS -_: CGGGCAGCTCAATCTCCGTGGATG-_NNP 3_CD '_POS ;_: LI_NNP :_:
          5_CD '_POS -_: TTGTGGCCATTCCCCCGTTGAACA-_NNP 3_CD '_POS )_) ._. To_TO amplify_VB the_DT 306_CD bp_NN
          fragment_NN ,_, two_CD rounds_NNS of_IN PCR_NNP were_VBD used_VBN :_: the_DT first_JJ round_NN
          used_VBD the_DT LO_NNP and_CC UO_NNP primers_NNS ,_, and_CC the_DT second_JJ round_NN used_VBD the_DT
          LO_NNP and_CC UI_NNP ._. To_TO amplify_VB the_DT 460_CD bp_NN fragment_NN ,_, two_CD rounds_NNS of_IN
          PCR_NNP were_VBD also_RB used_VBN ,_, the_DT LO_NNP and_CC UO_NNP in_IN the_DT first_JJ round_NN ,_, and_CC
          the_DT LI_NNP and_CC the_DT UO_NNP in_IN the_DT second_JJ round_NN ._.
        
        
          GST_NNP Pull_VB Down_IN Assay_NNP
          
          E_NNP ._. coli_NNS containing_VBG plasmids_NNS
          encoding_VBG GST-BTBD_NNP 1_CD or_CC GST-BTBD_NNP 2_CD were_VBD grown_VBN to_TO an_DT O_NNP ._. D_NNP ._. of_IN
          0_CD ._. 3_CD at_IN 25_CD °_NN C_NNP ,_, and_CC 2_CD %_NN EtOH_NNP was_VBD added_VBN just_RB prior_RB to_TO
          induction_NN with_IN 0_CD ._. 1_CD mM_NN IPTG_NNP for_IN 8_CD hrs_NNS ._. 
          E_NNP ._. coli_NNS extracts_NNS were_VBD prepared_VBN
          using_VBG a_DT French_JJ Pressure_NN Cell_NNP Press_NNP (_( American_NNP Instrument_NNP
          Company_NNP ,_, Silver_NNP Spring_NNP ,_, MD_NNP )_) ._. For_IN the_DT GST-pull-down_NNP assay_NN
          5_CD μg_NN of_IN GST_NNP or_CC the_DT GST-fusion_NNP proteins_NNS were_VBD mixed_VBN with_IN
          150_CD μl_NN HeLa_NNP cell_NN nuclear_JJ extracts_NNS (_( 5_CD ×_NN 10_CD 6_CD cells_NNS /_NN ml_NN )_) and_CC
          incubated_JJ for_IN 2_CD hr_NN at_IN 4_CD °_NN C_NNP (_( 0_CD ._. 25_CD M_NNP NaCl_NNP )_) ._. The_DT bead_NN pellets_NNS
          were_VBD then_RB washed_VBN 3_CD times_NNS with_IN ice_NN cold_JJ PBS_NNP before_IN
          solubilization_NN in_IN SDS-PAGE_NNP sample_NN buffer_NN ._.
        
        
          TOP_NNP 1_CD assays_NNS
          
            Supercoil_NNP relaxation_NN assay_NN
            HeLa_NNP nuclear_JJ extract_NN (_( 5_CD ng_NN )_) in_IN reaction_NN buffer_NN (_( 100_CD
            mM_NN Tris_NNP ._. HCl_NNP ,_, pH_NN 7_CD ._. 5_CD ,_, 50_CD mM_NN KCl_NNP ,_, 5_CD mM_NN MgCl_NNP 
            2_CD ,_, 0_CD ._. 1_CD mM_NN EDTA_NNP ,_, 15_CD μg_NN /_NN ml_NN BSA_NNP )_) was_VBD
            incubated_JJ with_IN 5_CD μg_NN of_IN purified_JJ GST_NNP or_CC GST-BTBD_NNP 2_CD on_IN ice_NN
            for_IN 15_CD min_NN before_IN the_DT addition_NN of_IN 0_CD ._. 25_CD μg_NN plasmid_NN and_CC
            incubation_NN at_IN 30_CD °_NN C_NNP for_IN 0_CD -_: 24_CD min_NN ._. Reactions_NNP were_VBD stopped_VBN
            by_IN adding_VBG SDS_NNP (_( 1_CD %_NN final_JJ )_) and_CC proteinase_NN K_NNP (_( 0_CD ._. 5_LS
            mg_NN /_NN reaction_NN )_) ._.
          
          
            DNA_NN cleavage_NN assays_NNS
            Purified_NNP TOP_NNP 1_CD was_VBD pre-incubated_JJ with_IN GST_NNP or_CC
            GST-BTBD_NNP 2_CD for_IN 20_CD min_NN before_IN addition_NN of_IN the_DT DNA_NNP
            substrate_NN ,_, which_WDT was_VBD either_CC an_DT end-labeled_JJ 36_CD bp_NN
            fragment_NN containing_VBG a_DT single_JJ strong_JJ TOP_NNP 1_CD cleavage_NN site_NN
            [_NN 24_CD ]_NN ,_, or_CC a_DT 161_CD bp_NN PvuII-HindIII_NNP fragment_NN of_IN
            pBluescript_NN (_( Stratagene_NNP )_) [_NN 25_CD ]_NN )_) ._. End_NN labeling_VBG of_IN the_DT
            DNA_NNP substrates_NNS was_VBD as_RB previously_RB described_VBD [_NN 24_CD 25_CD ]_NN ._.
            Cleavage_NNP reactions_NNS were_VBD continued_VBN for_IN 20_CD min_NN before_IN
            stopping_VBG with_IN 0_CD ._. 5_CD %_NN SDS_NNP ._.
          
        
      
      
        Abbreviations_NNP
        aa_NN ,_, amino_JJ acid_NN ;_: BTB_NNP :_: Broad-_NNP Complex_JJ ,_, Tramtrack_NNP and_CC
        Bric-a-brac_NNP ;_: GST_NNP ,_, glutathione-_NN S-_NNP transferase_NN ;_: NLS_NNP ,_, nuclear_JJ
        localization_NN signal_NN ;_: ORF_NNP ,_, open_JJ reading_NN frame_NN ;_: RT-PCR_NNP ,_,
        reverse_VB transcription_NN -_: polymerase_NN chain_NN reaction_NN ;_: TOP_NNP 1_CD ,_,
        DNA_NNP topoisomerase_NN I_PRP ._.
      
    
  
